Study Stopped
Low accrual and no further funding.
Role of Surgery for the Primary in Patients With Breast Cancer Stage IV.
1 other identifier
interventional
N/A
1 country
9
Brief Summary
The purpose of this study is to determine benefits of surgery for the primary in patients with breast cancer stage IV in randomized controlled study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Aug 2013
Longer than P75 for phase_3
9 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 15, 2013
CompletedFirst Posted
Study publicly available on registry
July 23, 2013
CompletedStudy Start
First participant enrolled
August 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2019
CompletedFebruary 27, 2015
February 1, 2015
1 year
July 15, 2013
February 26, 2015
Conditions
Outcome Measures
Primary Outcomes (1)
Overall survival
Five years
Secondary Outcomes (1)
Quality of life & Uncontrolled chest wall disease
Five years
Study Arms (2)
Controlled
NO INTERVENTIONNo surgery for primary breast tumor.
Study
EXPERIMENTALSurgery for primary breast tumor.
Interventions
Complete resection of primary breast tumor(Lumpectomy or mastectomy)
Eligibility Criteria
You may qualify if:
- Healthy breast cancer stage IV patients with resectable primary breast tumor.
- Resectable breast cancer stage IV patients who well response of visceral metastasis to systemic therapy and fit for surgery.
You may not qualify if:
- Breast cancer stage IV patients with local complication of primary breast tumor that require surgery for palliation such as uncontrolled bleeding,large and non-healing ulcer or intractable pain.
- Breast cancer stage IV patients with unresectable primary breast tumor or extensive chest wall disease.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- National Cancer Institute, Thailandlead
- Vichaiyut Hospitalcollaborator
Study Sites (9)
Division Head & Neck and Breast, Department of Surgery. Faculty of Medicine Siriraj Hospital
Bangkok Noi, Bangkok, 10700, Thailand
Department of Surgery, Faculty of Medicine Vajira Hospital.
Dusit, Bangkok, 10300, Thailand
Phyathai 2 Hospital
PhyaThai, Bangkok, 10400, Thailand
National Cancer Institute
Ratchathewi, Bangkok, 10400, Thailand
Phramongkutklao Hospital
Ratchathewi, Bangkok, 10400, Thailand
Chonburi Cancer Hospital
Muang Chonburi, Changwat Chon Buri, 20000, Thailand
Khon Kaen University
Muang, Changwat Khon Kaen, 40002, Thailand
Suratthani Cancer Hospital
Muang Suratthani, Changwat Surat Thani, 84100, Thailand
Udon Thani Cancer Hospital
Muang Udon Thani, Changwat Udon Thani, 41330, Thailand
Related Publications (6)
Khan SA, Stewart AK, Morrow M. Does aggressive local therapy improve survival in metastatic breast cancer? Surgery. 2002 Oct;132(4):620-6; discussion 626-7. doi: 10.1067/msy.2002.127544.
PMID: 12407345BACKGROUNDGnerlich J, Jeffe DB, Deshpande AD, Beers C, Zander C, Margenthaler JA. Surgical removal of the primary tumor increases overall survival in patients with metastatic breast cancer: analysis of the 1988-2003 SEER data. Ann Surg Oncol. 2007 Aug;14(8):2187-94. doi: 10.1245/s10434-007-9438-0. Epub 2007 May 24.
PMID: 17522944BACKGROUNDRapiti E, Verkooijen HM, Vlastos G, Fioretta G, Neyroud-Caspar I, Sappino AP, Chappuis PO, Bouchardy C. Complete excision of primary breast tumor improves survival of patients with metastatic breast cancer at diagnosis. J Clin Oncol. 2006 Jun 20;24(18):2743-9. doi: 10.1200/JCO.2005.04.2226. Epub 2006 May 15.
PMID: 16702580BACKGROUNDShien T, Kinoshita T, Shimizu C, Hojo T, Taira N, Doihara H, Akashi-Tanaka S. Primary tumor resection improves the survival of younger patients with metastatic breast cancer. Oncol Rep. 2009 Mar;21(3):827-32.
PMID: 19212646BACKGROUNDNeuman HB, Morrogh M, Gonen M, Van Zee KJ, Morrow M, King TA. Stage IV breast cancer in the era of targeted therapy: does surgery of the primary tumor matter? Cancer. 2010 Mar 1;116(5):1226-33. doi: 10.1002/cncr.24873.
PMID: 20101736BACKGROUNDNguyen DH, Truong PT, Alexander C, Walter CV, Hayashi E, Christie J, Lesperance M. Can locoregional treatment of the primary tumor improve outcomes for women with stage IV breast cancer at diagnosis? Int J Radiat Oncol Biol Phys. 2012 Sep 1;84(1):39-45. doi: 10.1016/j.ijrobp.2011.11.046. Epub 2012 Feb 11.
PMID: 22330986BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
AKANIST PIYAPANT, MD.,FRCST.
Phyathai2 Hospital , Bangkok, Thailand
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Surgical Oncologist.
Study Record Dates
First Submitted
July 15, 2013
First Posted
July 23, 2013
Study Start
August 1, 2013
Primary Completion
August 1, 2014
Study Completion
August 1, 2019
Last Updated
February 27, 2015
Record last verified: 2015-02